Will the new asthma and COPD injection be approved by the MHRA by June 30, 2025? | Binary | | | 21 days ago | |
Will Dupixent be approved for another indication by the FDA by end of 2024? | Binary | | | 3 months ago | |
Will Dupixent reach $1 billion in US sales for COPD treatment by end of 2024? | Binary | | | 3 months ago | |
What will be the revenue growth rate of Sanofi and Regeneron for fiscal year 2024? | Categorical | | | 3 months ago | |
What will be the global market approval status of the new injection by the end of 2025? | Categorical | | | 21 days ago | |
What will be the reduction in hospital admissions for asthma and COPD by the end of 2025? | Categorical | | | 21 days ago | |
Which company will acquire the rights to the new injection by the end of 2025? | Categorical | | | 21 days ago | |
Will the NHS adopt the new asthma and COPD injection by the end of 2025? | Binary | | | 21 days ago | |
Will a peer-reviewed study confirm the new injection's efficacy by the end of 2025? | Binary | | | 21 days ago | |
What will be the market share of Dupixent in the US COPD treatment market by end of 2024? | Categorical | | | 3 months ago | |
Will Sanofi or Regeneron stock price increase by more than 20% by end of 2024? | Binary | | | 3 months ago | |
How many new biologic treatments for COPD will be approved by the FDA by end of 2024? | Categorical | | | 3 months ago | |
